Crossref journal-article
Elsevier BV
Current Opinion in Biotechnology (78)
Bibliography

Felnerova, D., Viret, J.-F., Glück, R., & Moser, C. (2004). Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs. Current Opinion in Biotechnology, 15(6), 518–529.

Authors 4
  1. Diana Felnerova (first)
  2. Jean-François Viret (additional)
  3. Reinhard Glück (additional)
  4. Christian Moser (additional)
References 88 Referenced 229
  1. 10.1038/2081295a0 / Nature / Cation permeability of phospholipid model membranes: effect of narcotics by Bangham (1965)
  2. 10.1038/252252a0 / Nature / Liposomes as immunological adjuvants by Allison (1974)
  3. 10.1172/JCI116141 / J Clin Invest / Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A by Gluck (1992)
  4. 10.1586/14760584.2.2.189 / Expert Rev Vaccines / Virosomal adjuvanted antigen delivery systems by Moser (2003)
  5. 10.1016/S0264-410X(02)00540-6 / Vaccine / Liposomes and ISCOMs by Kersten (2003)
  6. 10.1016/S0168-3659(97)00261-7 / J Control Release / Development of liposomal anthracyclines: from basics to clinical applications by Gabizon (1998)
  7. 10.1016/S0163-7827(00)00011-4 / Prog Lipid Res / Current status of pH-sensitive liposomes in drug delivery by Drummond (2000)
  8. 10.1016/S0169-409X(01)00213-7 / Adv Drug Deliv Rev / Towards synthetic viruses by Zuber (2001)
  9. 10.2174/1381612043453009 / Curr Pharm Des / Current status of delivery systems to improve target efficacy of oligonucleotides by Shoji (2004)
  10. 10.2174/0929867033457421 / Curr Med Chem / Cationic liposomes as in vivo delivery vehicles by Templeton (2003)
  11. 10.1016/0009-3084(86)90066-6 / Chem Phys Lipids / Lipid polymorphism by Tilcock (1986)
  12. {'key': '10.1016/j.copbio.2004.10.005_bib12', 'first-page': '123', 'article-title': 'Fate and behavior of liposomes in vivo: a review of controlling factors', 'volume': '3', 'author': 'Senior', 'year': '1987', 'journal-title': 'Crit Rev Ther Drug Carrier Syst'} / Crit Rev Ther Drug Carrier Syst / Fate and behavior of liposomes in vivo: a review of controlling factors by Senior (1987)
  13. 10.1016/0005-2736(92)90034-J / Biochim Biophys Acta / Some negatively charged phospholipid derivatives prolong the liposome circulation in vivo by Park (1992)
  14. 10.1016/0005-2736(92)90194-Q / Biochim Biophys Acta / Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes by Woodle (1992)
  15. 10.1002/jgm.509 / J Gene Med / Physicochemical optimisation of plasmid delivery by cationic lipids by Tranchant (2004)
  16. 10.1021/ar9703241 / Acc Chem Res / Chemical approaches to triggerable lipid vesicles for drug and gene delivery by Guo (2003)
  17. 10.1021/bi00302a029 / Biochemistry / pH-induced destabilization of phosphatidylethanolamine-containing liposomes: role of bilayer contact by Ellens (1984)
  18. 10.1021/bc000110v / Bioconjug Chem / Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG–diortho ester–lipid conjugate by Guo (2001)
  19. 10.1016/j.phrs.2003.09.003 / Pharmacol Res / Pharmaco attributes of dioleoylphosphatidylethanolamine/cholesterylhemisuccinate liposomes containing different types of cleavable lipopolymers by Zhang (2004)
  20. 10.1158/1078-0432.CCR-03-0035 / Clin Cancer Res / Novel temperature-sensitive liposomes with prolonged circulation time by Lindner (2004)
  21. 10.1016/S0169-409X(01)00233-2 / Adv Drug Deliv Rev / The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors by Needham (2001)
  22. 10.1081/LPR-120004777 / J Liposome Res / Targeted liposomes for delivery of protein-based drugs into the cytoplasm of tumor cells by Mastrobattista (2002)
  23. 10.1023/A:1020198908574 / Biosci Rep / Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs by Bungener (2002)
  24. 10.1211/002235702928 / J Pharm Pharmacol / Enhancement of polyethylene glycol (PEG)-modified cationic liposome-mediated gene deliveries: effects on serum stability and transfection efficiency by Kim (2003)
  25. 10.1023/A:1020186505848 / Biosci Rep / Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol) by Allen (2002)
  26. 10.1124/jpet.103.060228 / J Pharmacol Exp Ther / Neutral and anionic liposome-encapsulated hemoglobin: effect of postinserted poly(ethylene glycol) -distearoylphosphatidylethanolamine on distribution and circulation kinetics by Awasthi (2004)
  27. 10.1016/S0304-3835(03)00099-5 / Cancer Lett / Development of Fab’ fragments of anti-GD(2) immunoliposomes entrapping doxorubicin for experimental therapy of human neuroblastoma by Brignole (2003)
  28. 10.1016/S0163-7827(03)00032-8 / Prog Lipid Res / Ligand-targeted liposomal anticancer drugs by Sapra (2003)
  29. 10.1016/S0076-6879(03)72019-9 / Methods Enzymol / Tat peptide-mediated intracellular delivery of liposomes by Levchenko (2003)
  30. 10.1016/S0092-8674(00)81843-7 / Cell / Intercellular trafficking and protein delivery by a herpesvirus structural protein by Elliott (1997)
  31. 10.2174/1389203033487298 / Curr Protein Pept Sci / TAT-liposomes: a novel intracellular drug carrier by Torchilin (2003)
  32. 10.1186/1472-6750-2-9 / BMC Biotechnol / Protein encapsulation in liposomes: efficiency depends on interactions between protein and phospholipid bilayer by Colletier (2002)
  33. 10.1158/1078-0432.CCR-1131-03 / Clin Cancer Res / In vitro and in vivo characterization of doxorubicin and vincristine coencapsulated within liposomes through use of transition metal ion complexation and pH gradient loading by Abraham (2004)
  34. {'key': '10.1016/j.copbio.2004.10.005_bib34', 'first-page': '439', 'article-title': 'Formulation kit for liposomal doxorubicin composed of lyophilized liposomes', 'volume': '23', 'author': 'Stevens', 'year': '2003', 'journal-title': 'Anticancer Res'} / Anticancer Res / Formulation kit for liposomal doxorubicin composed of lyophilized liposomes by Stevens (2003)
  35. 10.1016/S0076-6879(03)67003-5 / Methods Enzymol / Preparation and quantitation of small unilamellar liposomes and large unilamellar reverse-phase evaporation liposomes by Duzgunes (2003)
  36. 10.1073/pnas.1931005100 / Proc Natl Acad Sci USA / Engineering asymmetric vesicles by Pautot (2003)
  37. 10.1016/S0140-6736(75)92130-3 / Lancet / Formation of virosomes from influenza subunits and liposomes by Almeida (1975)
  38. 10.1016/S0264-410X(02)00541-8 / Vaccine / Immunostimulating reconstituted influenza virosomes by Zurbriggen (2003)
  39. 10.1111/j.1348-0421.2004.tb03502.x / Microbiol Immunol / Preparation of virosomes coated with the vesicular stomatitis virus glycoprotein as efficient gene transfer vehicles for animal cells by Shoji (2004)
  40. 10.1637/6082 / Avian Dis / Development of a virosome vaccine for Newcastle disease virus by Kapczynski (2003)
  41. 10.5483/BMBRep.2002.35.5.459 / J Biochem Mol Biol / Effect of lipid compositions on gene transfer into 293 cells using Sendai F/HN-virosomes by Kim (2002)
  42. 10.1016/S0264-410X(02)00567-4 / Vaccine / Novel approaches in the development of immunopotentiating reconstituted influenza virosomes as efficient antigen carrier systems by Gluck (2003)
  43. {'key': '10.1016/j.copbio.2004.10.005_bib43', 'first-page': '437', 'article-title': 'Targeting her-2/neu with antirat Neu virosomes for cancer therapy', 'volume': '62', 'author': 'Waelti', 'year': '2002', 'journal-title': 'Cancer Res'} / Cancer Res / Targeting her-2/neu with antirat Neu virosomes for cancer therapy by Waelti (2002)
  44. 10.1016/S0264-410X(02)00542-X / Vaccine / Influenza virosomes: combining optimal presentation of hemagglutinin with immunopotentiating activity by Huckriede (2003)
  45. 10.1002/eji.1830251236 / Eur J Immunol / T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction? by Bachmann (1995)
  46. 10.1016/j.vaccine.2003.08.019 / Vaccine / Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation by Schumacher (2004)
  47. 10.1016/S0264-410X(02)00512-1 / Vaccine / Inflexal V a trivalent virosome subunit influenza vaccine: production by Mischler (2002)
  48. 10.1016/S0163-7827(99)00017-X / Prog Lipid Res / IRIV-adjuvanted hepatitis A vaccine: in vivo absorption and biophysical characterization by Zurbriggen (2000)
  49. 10.1172/JCI116141 / J Clin Invest / Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A by Gluck (1992)
  50. 10.1128/IAI.71.8.4749-4758.2003 / Infect Immun / Induction of parasite growth-inhibitory antibodies by a virosomal formulation of a peptidomimetic of loop I from domain III of Plasmodium falciparum apical membrane antigen 1 by Mueller (2003)
  51. 10.1093/intimm/dxf026 / Int Immunol / In vitro studies of core peptide-bearing immunopotentiating reconstituted influenza virosomes as a non-live prototype vaccine against hepatitis C virus by Hunziker (2002)
  52. 10.1016/S0264-410X(02)00353-5 / Vaccine / Influenza virosomes are an efficient delivery system for respiratory syncytial virus-F antigen inducing humoral and cell-mediated immunity by Cusi (2002)
  53. 10.1016/S0959-8049(01)00241-6 / Eur J Cancer / Tumour-associated antigen (TAA)-specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes by Correale (2001)
  54. 10.1002/(SICI)1097-0215(19980831)77:5<728::AID-IJC11>3.0.CO;2-Y / Int J Cancer / Delivery to cancer cells of antisense L-myc oligonucleotides incorporated in fusogenic, cationic-lipid-reconstituted influenza-virus envelopes (cationic virosomes) by Waelti (1998)
  55. 10.1016/S0168-1702(00)00254-9 / Virus Res / Localization of a new neutralizing epitope on the mumps virus hemagglutinin–neuraminidase protein by Cusi (2001)
  56. 10.1038/sj.bjc.6601028 / Br J Cancer / In vivo study of the GC90/IRIV vaccine for immune response and autoimmunity into a novel humanised transgenic mouse by Scardino (2003)
  57. {'key': '10.1016/j.copbio.2004.10.005_bib57', 'first-page': '253', 'article-title': 'Engineered liposomes for potential α-particle therapy of metastatic cancer', 'volume': '45', 'author': 'Sofou', 'year': '2004', 'journal-title': 'J Nucl Med'} / J Nucl Med / Engineered liposomes for potential α-particle therapy of metastatic cancer by Sofou (2004)
  58. 10.1081/LPR-120017485 / J Liposome Res / Anti-neovascular therapy by use of liposomes targeted to angiogenic vessels by Oku (2003)
  59. 10.1002/jbm.a.20235 / J Biomed Mater Res / Pentapeptide YIGSR-mediated HT-1080 fibrosarcoma cells targeting of adriamycin encapsulated in sterically stabilized liposomes by Lopez-Barcons (2004)
  60. 10.1038/sj.bjc.6601341 / Br J Cancer / Efficacy of immunoliposomes on cancer models in a cell-surface-antigen-density-dependent manner by Hosokawa (2003)
  61. 10.1158/1078-0432.CCR-03-0376 / Clin Cancer Res / Improved outcome when B-cell lymphoma is treated with combinations of immunoliposomal anticancer drugs targeted to both the CD19 and CD20 epitopes by Sapra (2004)
  62. 10.1177/002215540305100915 / J Histochem Cytochem / Intravenous liposomal prednisolone downregulates in situ TNF-α production by T-cells in experimental autoimmune encephalomyelitis by Schmidt (2003)
  63. 10.1182/blood-2001-11-0061 / Blood / Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model by Jordan (2003)
  64. 10.1023/A:1025057216492 / Pharm Res / Targeting and blocking B7 costimulatory molecules on antigen-presenting cells using CTLA4Ig-conjugated liposomes: in vitro characterization and in vivo factors affecting biodistribution by Park (2003)
  65. 10.1002/art.11140 / Arthritis Rheum / Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes by Metselaar (2003)
  66. 10.1067/mai.2003.104 / J Allergy Clin Immunol / Efficacy of liposomal budesonide in experimental asthma by Konduri (2003)
  67. 10.1046/j.1365-2133.2002.04800.x / Br J Dermatol / Liposomal tacrolimus lotion as a novel topical agent for treatment of immune-mediated skin disorders: experimental studies in a murine model by Erdogan (2002)
  68. 10.1081/DDC-120025872 / Drug Dev Ind Pharm / Continuous release of interleukin-2 from liposomal IL-2 (mixture of interleukin-2 and liposomes) after subcutaneous administration to mice by Kanaoka (2003)
  69. 10.1093/jac/48.3.333 / J Antimicrob Chemother / Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies by Schiffelers (2001)
  70. 10.1080/1042819031000099733 / Leuk Lymphoma / Cellular pharmacology of P-ethoxy antisense oligonucleotides targeted to Bcl-2 in a follicular lymphoma cell line by Gutierrez-Puente (2003)
  71. 10.1016/S0168-3659(02)00484-4 / J Control Release / Remarkable induction of apoptosis in cancer cells by a novel cationic liposome complexed with a bcl-2 antisense oligonucleotide by Noguchi (2003)
  72. 10.1007/s00262-003-0416-5 / Cancer Immunol Immunother / Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma by Ito (2004)
  73. 10.4161/cbt.3.2.622 / Cancer Biol Ther / Pharmacodynamic behavior of liposomal antisense oligonucleotides targeting Her-2/neu and vascular endothelial growth factor in an ascitic MDA435/LCC6 human breast cancer model by Waterhouse (2004)
  74. 10.1016/S0304-3835(03)00107-1 / Cancer Lett / Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment by Brignole (2003)
  75. 10.1089/10430340460732472 / Hum Gene Ther / Human gene therapy for malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human interferon β gene using cationic liposomes by Yoshida (2004)
  76. 10.1016/S0966-3274(03)00002-9 / Transpl Immunol / Genetic modification of cold-preserved renal grafts using HSP70 or bcl-2 HVJ-liposome method by Kita (2003)
  77. {'key': '10.1016/j.copbio.2004.10.005_bib77', 'first-page': '552', 'article-title': 'Antisense oligonucleotides to Syk kinase: a novel therapeutic approach for respiratory disorders', 'volume': '4', 'author': 'Ulanova', 'year': '2003', 'journal-title': 'Curr Opin Investig Drugs'} / Curr Opin Investig Drugs / Antisense oligonucleotides to Syk kinase: a novel therapeutic approach for respiratory disorders by Ulanova (2003)
  78. 10.1021/bc034134o / Bioconjug Chem / Liposomes with differential lipid components exert differential adjuvanticity in antigen-liposome conjugates via differential recognition by macrophages by Tanaka (2004)
  79. 10.1016/S0264-410X(03)00172-5 / Vaccine / Effective induction of CD8+ T-cell response using CpG oligodeoxynucleotides and HER-2/neu-derived peptide co-encapsulated in liposomes by Li (2003)
  80. {'key': '10.1016/j.copbio.2004.10.005_bib80', 'first-page': '465', 'article-title': 'Organ-specific gene expression in the rhesus monkey eye following intravenous non-viral gene transfer', 'volume': '9', 'author': 'Zhang', 'year': '2003', 'journal-title': 'Mol Vis'} / Mol Vis / Organ-specific gene expression in the rhesus monkey eye following intravenous non-viral gene transfer by Zhang (2003)
  81. 10.1016/S0264-410X(03)00042-2 / Vaccine / The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunogenicity and liposome adjuvanticity by Wu (2003)
  82. 10.1089/104454904322759911 / DNA Cell Biol / Evaluation of genetic immunization adjuvants to improve the effectiveness of a human immunodeficiency virus type 2 (HIV-2) envelope DNA vaccine by Locher (2004)
  83. 10.1046/j.1365-2222.2002.01514.x / Clin Exp Allergy / Liposome-entrapped D. pteronyssinus vaccination in mild asthma patients: effect of 1-year double-blind, placebo-controlled trial on inflammation, bronchial hyperresponsiveness and immediate and late bronchial responses to the allergen by Alvarez (2002)
  84. 10.1016/j.vaccine.2003.09.030 / Vaccine / A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice by Mazumdar (2004)
  85. 10.1016/S0264-410X(98)00361-2 / Vaccine / Immunogenicity of IRIV — versus alum-adjuvanted diphtheria and tetanus toxoid vaccines in influenza primed mice by Zurbriggen (1999)
  86. 10.1016/S0014-5793(01)03112-X / FEBS Lett / Targeting influenza virosomes to ovarian carcinoma cells by Mastrobattista (2001)
  87. 10.1080/02652040010019550 / J Microencapsul / Enhanced cytotoxicity of doxorubicin encapsulated in liposomes with reconstituted Sendai F-proteins by Cho (2001)
  88. 10.1089/aid.1992.8.1823 / AIDS Res Hum Retroviruses / Properties of HIV membrane reconstituted from its recombinant gp160 envelope glycoprotein by Cornet (1992)
Dates
Type When
Created 20 years, 10 months ago (Nov. 3, 2004, 7:09 a.m.)
Deposited 6 years, 7 months ago (Feb. 2, 2019, 3:51 a.m.)
Indexed 5 days, 20 hours ago (Aug. 29, 2025, 6:26 a.m.)
Issued 20 years, 9 months ago (Dec. 1, 2004)
Published 20 years, 9 months ago (Dec. 1, 2004)
Published Print 20 years, 9 months ago (Dec. 1, 2004)
Funders 0

None

@article{Felnerova_2004, title={Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs}, volume={15}, ISSN={0958-1669}, url={http://dx.doi.org/10.1016/j.copbio.2004.10.005}, DOI={10.1016/j.copbio.2004.10.005}, number={6}, journal={Current Opinion in Biotechnology}, publisher={Elsevier BV}, author={Felnerova, Diana and Viret, Jean-François and Glück, Reinhard and Moser, Christian}, year={2004}, month=dec, pages={518–529} }